(2023) Kidney biopsy findings in patients with SARS-CoV-2 infection or after COVID-19 vaccination. CJASN [In press]
Prof. Dr. Peter F. ZipfelInfection Biology · Head International Leibniz Research School · Speaker +49 3641 532-1301 firstname.lastname@example.org
Main Research Areas
- Immune escape of human pathogenic micro-organisms
- Infection-associated function of the complement system
- Genetic susceptibility for infections
|Since 2000||Professor for infection biology, Friedrich-Schiller-University Jena (FSU Jena)|
|Since 2000||Head of the department infection biology, Leibniz-Institute for Natural Product Research and Infection Biology – Hans-Knöll-Institute Jena|
|1999||Nontenured professor, University Hamburg|
|1993||Habilitation in immunology and molecular biology, University Hamburg|
|1989-2000||Group head at the Bernhard-Nocht-Institute for tropical medicine Hamburg|
|1989||Visiting associate, Laboratory of Immunoregulation, National Institutes of Health, Bethesda, Maryland, USA|
|1985-1988||Postdoc, Laboratory of Immunoregulation, National Institutes of Health, Bethesda, Maryland, USA, funded by the German Academic Exchange Service (DAAD)|
|1984||PhD as Dr. rer. nat., University Bremen|
|1980-1985||Research assistant, University Bremen|
|1980||Diploma in biology, University Bremen|
Awards · Appointments · Scientific Activities
|Since 2009||Member at the editorial board of molecular immunology, frontiers in innate immunity|
|2009||Excellence award from the Deutsche Gesellschaft für Hygiene und Mikrobiologie|
|Since 2008||Representative of the graduate school International Leibniz Research School for Microbial and Biomolecular Interactions (ILRS)|
|2008||EFIS lecture award of the European Federation of Immunological Societies|
|Since 2007||Principal investigator of the excellence graduate school Jena School for Microbial Communication (JSMC)|
|2007||Heinz Spitzbart award of the European Society for Infectious Diseases in Obstetrics and Gynaecology (ESIDOG)|
|Since 2006||Principal investigator of the graduate school International Leibniz Research School for Microbial and Biomolecular Interactions (ILRS)|
|2007-2011||President of the European Complement Network|
|2005 – 2012||Board member of the European Complement Network|
|2004||Thuringian research award|
|Since 2002||Deputy Director of the Leibniz-Institute for Natural Product Research and Infection Biology – Hans-Knöll-Institute Jena|
|Since 2000||Project leader for infection biology, L2|
|1999-2001||Member at the editorial board of experimental and clinical immunology, thrombosis and haemostasis, section editor molecular immunology
Member of the European Working Party on the Genetics of Complement mediated Kidney Diseases, Deutsche Gesellschaft für Hygiene und Mikrobiologie (DGHM), Deutsche Gesellschaft für Immunologie, Gesellschaft für Genetik, Gesellschaft für Nephrologie
(2023) The classical pathway triggers pathogenic complement activation in membranous nephropathy. Nat Commun 14(1), 473.
(2022) Breast cancer cell-based ELISA: a potential material for better detection of heparin-induced thrombocytopenia antibodies. J Mater Chem B 10(38), 7708-7716.
(2022) Candida albicans induces cross-kingdom miRNA trafficking in human monocytes to promote fungal growth. mBio 13(1), e0356321.
(2022) A synthetic protein as efficient multitarget regulator against complement over-activation. Commun Biol 5(1), 152.
(2022) An interdisciplinary diagnostic approach to guide therapy in C3 glomerulopathy. Front Immunol 13, 826513.
(2022) Low molecular weight polysialic acid binds to properdin and reduces the activity of the alternative complement pathway. Sci Rep 12(1), 5818.
(2022) Novel FHR2 variants in atypical haemolytic uremic syndrome: a case study of translational medicine approach in renal transplantation. Front Immunol 13, 1008294.
(2022) Molecular mapping of urinary complement peptides in kidney diseases. Proteomes 9(4), 49.
(2022) Bacterial infection possibly causing autoimmunity: Tropheryma whipplei and membranous nephropathy. Lancet 400(10366), 1882-1883.